PD-Rx Pharmaceuticals, Inc. (PDRX)

USD 3.2

(-13.51%)

Revenue Summary of PD-Rx Pharmaceuticals, Inc.

  • PD-Rx Pharmaceuticals, Inc.'s latest annual revenue in 2022 was 21.27 Million USD , down -25.92% from previous year.
  • PD-Rx Pharmaceuticals, Inc.'s latest quarterly revenue in 2022 FY was 21.27 Million USD , down -25.92% from previous quarter.
  • PD-Rx Pharmaceuticals, Inc. reported a annual revenue of 28.71 Million USD in annual revenue 2021, up 32.93% from previous year.
  • PD-Rx Pharmaceuticals, Inc. reported a annual revenue of 21.6 Million USD in annual revenue 2020, up 2.74% from previous year.
  • PD-Rx Pharmaceuticals, Inc. reported a quarterly revenue of 28.71 Million USD for 2021 FY, up 32.93% from previous quarter.
  • PD-Rx Pharmaceuticals, Inc. reported a quarterly revenue of 21.6 Million USD for 2020 FY, up 2.74% from previous quarter.

Annual Revenue Chart of PD-Rx Pharmaceuticals, Inc. (2022 - 2012)

Historical Annual Revenue of PD-Rx Pharmaceuticals, Inc. (2022 - 2012)

Year Revenue Revenue Growth
2022 21.27 Million USD -25.92%
2021 28.71 Million USD 32.93%
2020 21.6 Million USD 2.74%
2019 21.02 Million USD 0.74%
2018 20.87 Million USD -16.41%
2017 24.96 Million USD -3.93%
2016 25.98 Million USD 21.06%
2015 21.46 Million USD 10.73%
2014 19.38 Million USD -33.43%
2013 29.12 Million USD 11.92%
2012 26.01 Million USD 0.0%

Peer Revenue Comparison of PD-Rx Pharmaceuticals, Inc.

Name Revenue Revenue Difference
China Medicine Corporation 64.75 Million USD 67.149%
DH Enchantment Inc. 686.00 USD -3100718.367%
Exlites Holdings International, Inc. 18.74 Thousand USD -113409.146%
Itonis, Inc. 1801.00 USD -1181000.167%
One Step Vending Corp. - USD -Infinity%
MediPal Holdings Corporation 23.51 Billion USD 99.91%
Pharmagen, Inc. 4813.05 USD -441857.054%
Suzuken Co., Ltd. 15.76 Billion USD 99.865%